Intended for healthcare professionals


British soldiers are “guinea pigs” for new use of blood clotting agent

BMJ 2006; 333 doi: (Published 21 September 2006) Cite this as: BMJ 2006;333:618
  1. Owen Dyer
  1. London

    British soldiers in Iraq are being treated for traumatic injury with an unlicensed blood clotting agent that has yet to complete clinical trials.

    The drug, NovoSeven, also called recombinant factor VIIa, has been licensed for the treatment of haemophilia since 1999 but is still undergoing phase III trials as treatment for traumatic bleeding. It was first used in a military setting four years ago, on a wounded Israeli soldier, and has since been used by US forces in …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription